ABVC Company Profile and Key Details

Q: Who are the executives of ABVC?

Dr. Chi-Hsin King Ph.D.Chief Scientific OfficerMr. Eugene JiangChairman & Chief Bus. OfficerDr. Uttam Yashwant PatilChief Executive OfficerMr. Leeds ChowChief Financial Officer & Principal Accounting OfficerDr. Tsung-Shann Jiang Ph.D.Chief Scientific Officer, Chief Strategy Officer & DirectorDr. Tsung-Shann Jiang EMBA, Ph.D.Chief Scientific Officer & DirectorDr. Uttam Yashwant Patil Ph.D.Chief Executive OfficerDr. Howard Doong M.D., Ph.D.Pres & Chief Executive Officer

NASDAQ : ABVC

ABVC BioPharma

$1.10

0.03+2.80%

At Close 4:00 PM

63.71

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ABVC BioPharma, Inc. (ABVC) stock surged +2.80%, trading at $1.10 on NASDAQ, up from the previous close of $1.07. The stock opened at $1.03, fluctuating between $1.02 and $1.10 in the recent session.

Stock Snapshot

1.07

Prev. Close

15.94M

Market Cap

1.015

Day Low

-2.82

P/E Ratio

-0.39

EPS (TTM)

-0.53

Cash Flow per Share

1.03

Open

14.49M

Number of Shares

1.1

Day High

92.6%

Free Float in %

1.11

Book Value

66.69K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 19, 2026	1.09	1.11	1.01	1.10	66.72K
May 18, 2026	1.10	1.16	1.00	1.07	129.67K
May 15, 2026	1.08	1.10	1.05	1.09	68.59K
May 14, 2026	1.07	1.09	1.04	1.08	76.39K
May 13, 2026	1.06	1.09	1.05	1.07	96.71K
May 12, 2026	1.02	1.08	1.01	1.05	79.2K
May 11, 2026	1.06	1.09	1.01	1.02	78.16K
May 08, 2026	1.10	1.12	1.06	1.06	67.73K
May 07, 2026	1.12	1.15	1.10	1.10	73.08K
May 06, 2026	1.03	1.12	1.01	1.10	159.62K
May 05, 2026	1.08	1.09	1.02	1.03	78.53K
May 04, 2026	1.04	1.09	1.02	1.05	78.06K
Apr 30, 2026	1.05	1.06	1.02	1.03	54.58K
Apr 29, 2026	1.09	1.09	1.02	1.03	37.63K
Apr 28, 2026	1.10	1.12	1.06	1.07	28.74K
Apr 27, 2026	1.07	1.13	1.03	1.08	55.58K
Apr 23, 2026	1.18	1.18	1.11	1.14	49.81K
Apr 22, 2026	1.27	1.29	1.16	1.18	109.07K
Apr 21, 2026	1.30	1.31	1.23	1.27	50.91K
Apr 20, 2026	1.32	1.36	1.25	1.30	65.3K

Contact Details

Fremont, CA 94538

United States

https://www.abvcpharma.com 510 668 0881

About Company

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Stock Peers

ARGX

21.51+2.77%

argenx SE$797.77 REGN

0.62+0.10%

Regeneron Pharmaceuticals, Inc.$630.30 UTHR

-0.19-0.03%

United Therapeutics Corporation$566.80 MDGL

-10.41-1.99%

Madrigal Pharmaceuticals, Inc.$511.82 VRTX

-2.27-0.52%

Vertex Pharmaceuticals Incorporated$434.31 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

0.08+0.02%

Praxis Precision Medicines, Inc.$320.61 ALNY

8.03001+2.81%

Alnylam Pharmaceuticals, Inc.$294.30 KRYS

1.55+0.53%

Krystal Biotech, Inc.$293.30 ASND

0.34+0.14%

Ascendis Pharma A/S$237.98

Frequently Asked Questions

What is the current ABVC BioPharma, Inc. (ABVC) stock price?

ABVC BioPharma, Inc. (NASDAQ: ABVC) stock price is $1.10 in the last trading session. During the trading session, ABVC stock reached the peak price of $1.10 while $1.02 was the lowest point it dropped to. The percentage change in ABVC stock occurred in the recent session was 2.8% while the dollar amount for the price change in ABVC stock was $0.03.

ABVC's industry and sector of operation?

The NASDAQ listed ABVC is part of Biotechnology industry that operates in the broader Healthcare sector. ABVC BioPharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABVC?

Dr. Chi-Hsin King Ph.D.
Chief Scientific Officer
Mr. Eugene Jiang
Chairman & Chief Bus. Officer
Dr. Uttam Yashwant Patil
Chief Executive Officer
Mr. Leeds Chow
Chief Financial Officer & Principal Accounting Officer
Dr. Tsung-Shann Jiang Ph.D.
Chief Scientific Officer, Chief Strategy Officer & Director
Dr. Tsung-Shann Jiang EMBA, Ph.D.
Chief Scientific Officer & Director
Dr. Uttam Yashwant Patil Ph.D.
Chief Executive Officer
Dr. Howard Doong M.D., Ph.D.
Pres & Chief Executive Officer

How ABVC did perform over past 52-week?

ABVC's closing price is 25% higher than its 52-week low of $0.88 where as its distance from 52-week high of $5.48 is -79.93%.

How many employees does ABVC have?

Number of ABVC employees currently stands at 16.

Link for ABVC official website?

Official Website of ABVC is: https://www.abvcpharma.com

How do I contact ABVC?

ABVC could be contacted at phone 510 668 0881 and can also be accessed through its website. ABVC operates from 44370 Old Warm Springs Boulevard, Fremont, CA 94538, United States.

How many shares of ABVC are traded daily?

ABVC stock volume for the day was 66.69K shares. The average number of ABVC shares traded daily for last 3 months was 92.14K.

What is the market cap of ABVC currently?

The market value of ABVC currently stands at $15.94M with its latest stock price at $1.10 and 14.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	16
Beta	0.27
Sales or Revenue	$152.43K
5Y Sales Change%	4.866%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	16
Beta	0.27
Sales or Revenue	$152.43K
5Y Sales Change%	4.866%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ABVC Company Profile and Key Details

ABVC BioPharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways